Compare Abbott India with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AJANTA PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AJANTA PHARMA ABBOTT INDIA/
AJANTA PHARMA
 
P/E (TTM) x 49.0 24.4 201.0% View Chart
P/BV x 15.8 6.8 233.8% View Chart
Dividend Yield % 0.4 0.5 83.4%  

Financials

 ABBOTT INDIA   AJANTA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
AJANTA PHARMA
Mar-19
ABBOTT INDIA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs8,8341,422 621.3%   
Low Rs5,458898 608.0%   
Sales per share (Unadj.) Rs1,731.1233.5 741.3%  
Earnings per share (Unadj.) Rs211.944.0 482.0%  
Cash flow per share (Unadj.) Rs219.952.2 421.6%  
Dividends per share (Unadj.) Rs65.009.00 722.2%  
Dividend yield (eoy) %0.90.8 117.2%  
Book value per share (Unadj.) Rs945.2255.1 370.6%  
Shares outstanding (eoy) m21.2588.02 24.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.15.0 83.1%   
Avg P/E ratio x33.726.4 127.8%  
P/CF ratio (eoy) x32.522.2 146.1%  
Price / Book Value ratio x7.64.5 166.3%  
Dividend payout %30.720.5 149.8%   
Avg Mkt Cap Rs m151,848102,081 148.8%   
No. of employees `0003.56.8 51.3%   
Total wages/salary Rs m4,3564,307 101.1%   
Avg. sales/employee Rs Th10,555.53,022.6 349.2%   
Avg. wages/employee Rs Th1,249.9633.4 197.3%   
Avg. net profit/employee Rs Th1,292.2569.1 227.1%   
INCOME DATA
Net Sales Rs m36,78620,554 179.0%  
Other income Rs m1,133211 537.4%   
Total revenues Rs m37,91920,765 182.6%   
Gross profit Rs m6,0475,664 106.8%  
Depreciation Rs m169721 23.5%   
Interest Rs m2312 194.0%   
Profit before tax Rs m6,9895,143 135.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4851,273 195.2%   
Profit after tax Rs m4,5033,870 116.4%  
Gross profit margin %16.427.6 59.7%  
Effective tax rate %35.624.8 143.7%   
Net profit margin %12.218.8 65.0%  
BALANCE SHEET DATA
Current assets Rs m27,61011,812 233.7%   
Current liabilities Rs m8,5693,776 226.9%   
Net working cap to sales %51.839.1 132.4%  
Current ratio x3.23.1 103.0%  
Inventory Days Days6077 77.8%  
Debtors Days Days2782 33.6%  
Net fixed assets Rs m1,05714,398 7.3%   
Share capital Rs m213175 121.2%   
"Free" reserves Rs m19,87322,277 89.2%   
Net worth Rs m20,08622,452 89.5%   
Long term debt Rs m07 0.0%   
Total assets Rs m29,40926,962 109.1%  
Interest coverage x311.6444.3 70.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.8 164.1%   
Return on assets %15.414.4 106.9%  
Return on equity %22.417.2 130.1%  
Return on capital %34.923.0 152.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36910,682 3.5%   
Fx outflow Rs m4,9182,102 234.0%   
Net fx Rs m-4,5498,580 -53.0%   
CASH FLOW
From Operations Rs m4,9913,748 133.2%  
From Investments Rs m-2,570-2,228 115.4%  
From Financial Activity Rs m-1,428-1,475 96.8%  
Net Cashflow Rs m99345 2,197.6%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 1.6 509.7%  
FIIs % 0.1 7.6 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.0 100.6%  
Shareholders   18,270 20,968 87.1%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  J.B.CHEMICALS  NEULAND LABS  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday(Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS